Dutch Cochrane Centre, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands.
PLoS One. 2012;7(8):e42812. doi: 10.1371/journal.pone.0042812. Epub 2012 Aug 15.
Publication and selective outcome reporting bias are a threat to the validity of systematic reviews. Extensive searching for additional trials in prospective trial registers could reduce this problem. We have evaluated how authors of Cochrane systematic reviews currently make use of trial registers as an additional source for the identification of potentially eligible trials.
METHODOLOGY/PRINCIPAL FINDINGS: We included 210 systematic Cochrane reviews of interventions published between 2008 and 2010 of which the protocol was first published in 2008. When prospective trial registers were searched we recorded the names of the register(s), the authors' motive(s) and if they yielded any extra trials. In 80 reviews (38.1%) the authors had searched in one or more prospective trial register(s) of which 55% had searched in overlapping search portals and individual registers. Most frequently assessed were the MetaRegister (66.3%) and Clinicaltrials.gov (60%) which is in sharp contrast of other registers or portals like the WHO ICTRP Search Portal (20%). Reported motives to use registers were to identify ongoing trials (83.3%), to identify unpublished outcomes or trials (23.5%), to identify recently published trials (11.8%), or to identify any relevant trial (3.9%).In 28 reviews (35%) the authors had selected (ongoing) trials identified in trial registers as potentially eligible.
Trial registers as an additional source of information are gaining acknowledgement amongst Cochrane reviewers. Nevertheless, searches seem to be inefficient as overlapping databases are frequently consulted, while the WHO ICTRP Search Portal that includes the data from all approved registers worldwide is being underused. Moreover, the emphasis is now on the identification of ongoing trials, although the prospective registers offer a broader potential. Further familiarity of registers and guidance how to search and to report will help to implement this as a common method and utilize the full potential of prospective trial registers for systematic reviews.
发表偏倚和选择性结果报告偏倚会对系统评价的有效性构成威胁。在前瞻性试验登记处广泛搜索额外的试验可以减少这个问题。我们评估了 Cochrane 系统评价的作者目前如何将试验登记处作为额外的来源,以确定潜在合格的试验。
方法/主要发现:我们纳入了 210 项发表于 2008 年至 2010 年的 Cochrane 系统评价干预措施,其中方案于 2008 年首次发表。当检索前瞻性试验登记处时,我们记录了登记处的名称、作者的动机以及是否有额外的试验。在 80 项综述(38.1%)中,作者在一个或多个前瞻性试验登记处进行了检索,其中 55%的检索在重叠的检索门户和个别登记处进行。最常评估的是 MetaRegister(66.3%)和 Clinicaltrials.gov(60%),这与其他登记处或门户形成鲜明对比,如世界卫生组织 ICTRP 搜索门户(20%)。报告使用登记处的动机包括识别正在进行的试验(83.3%)、识别未发表的结局或试验(23.5%)、识别最近发表的试验(11.8%)或识别任何相关试验(3.9%)。在 28 项综述(35%)中,作者选择了试验登记处中确定的(正在进行的)试验作为潜在合格的试验。
试验登记处作为额外的信息来源,在 Cochrane 评论员中得到了认可。然而,搜索似乎效率低下,因为经常咨询重叠的数据库,而世界卫生组织 ICTRP 搜索门户,其中包括来自世界各地所有批准的登记处的数据,却未得到充分利用。此外,重点现在是识别正在进行的试验,尽管前瞻性登记处具有更广泛的潜力。进一步熟悉登记处以及如何搜索和报告的指南将有助于将其作为一种共同方法实施,并充分利用前瞻性试验登记处对系统评价的潜力。